Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator Initiated Pilot Study to Evaluate the Impact on Glucose Control and Safety of the Eversense Continuous Glucose Monitoring System in Children and Adolescents

NCT03815552 is registered in ClinicalTrials.gov with Kinderkrankenhaus auf der Bult as lead sponsor.

NCT NCT03815552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator Initiated Pilot Study to Evaluate the Impact on Glucose Control and Safety of the Eversense Continuous Glucose Monitoring System in Children and Adolescents
Lead sponsor
Kinderkrankenhaus auf der Bult
Phase
Not applicable
Overall status
Completed
Start date
October 8, 2018
Completion date
September 11, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

self care